Comparative Evaluation of Growth Factor Bioavailability–Enhanced Allograft Vs Autogenous Bone Graft in Anterior Maxillary Ridge Augmentation - Report - DentalSpire
Advertisement
Comparative Evaluation of Growth Factor Bioavailability–Enhanced Allograft Vs Autogenous Bone Graft in Anterior Maxillary Ridge Augmentation
Clinical Report: Comparative Evaluation of Growth Factor Bioavailability–Enhanced Allograft
Overview
This case report evaluates the effectiveness of a growth factor bioavailability–enhanced allograft (GFBA) in anterior maxillary ridge augmentation. Both grafting methods resulted in successful ridge augmentation and stable implant placement after 11 months.
Background
Alveolar ridge deficiencies can hinder implant placement, particularly in the anterior maxilla. Autogenous bone grafting is the standard treatment but carries risks of donor site morbidity. The introduction of GFBA aims to provide a viable alternative with enhanced biological signaling for bone regeneration.
Data Highlights
Both GFBA and autogenous grafts demonstrated successful ridge augmentation at 11 months, with stable peri-implant bone levels confirmed by follow-up radiographs.
Key Findings
GFBA showed a homogeneous trabecular pattern and advanced integration at the augmentation site.
Autogenous graft demonstrated ongoing remodeling and integration.
Implants were successfully placed at both grafted sites.
Significant dimensional changes can occur post-extraction, necessitating ridge augmentation.
Clinical Implications
Understanding the biological properties of graft materials can aid in selecting appropriate treatment options for alveolar ridge augmentation.
Conclusion
Both methods achieved successful outcomes in this case report.
